Evidence map›Paper›PMID 30701402›Full record

ReviewAMB Express2019

Microbial hexuronate catabolism in biotechnology.

Joosu Kuivanen, Alessandra Biz, Peter Richard

Open access · goldAbstract readReview
In one paragraph

Review in AMB Express, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
8.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 43 citations in OpenAlex.

  1. An electron transport complex required in the gut sensitizesProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Dissimilar gene repertoires ofFrontiers in plant science · 2023
    Article
  6. Article
  7. Article
  8. Standard Candles for Dating Microbial Lineages.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. "Frontiers in microbiology · 2020
    Article
  16. Review
  17. Article
  18. Article
  19. A Novel D-Galacturonate Fermentation Pathway inFrontiers in microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Joosu KuivanenVTT Technical Research Centre of Finland Ltd, PO box 1000, 02044 VTT, Espoo, Finland.
Alessandra BizDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, 200 College st, Toronto, ON, M5S 3E5, Canada.
Peter RichardVTT Technical Research Centre of Finland Ltd, PO box 1000, 02044 VTT, Espoo, Finland. Peter.Richard@vtt.fi.ORCID http://orcid.org/0000-0003-0922-6092
VTT Technical Research Centre of Finland · FIUniversity of Toronto · CA

Funding

Academy of Finland 311743Academy of Finland 311958CNPq Process 20732172015-9
6 · The paper itself

Abstract

The most abundant hexuronate in plant biomass is D-galacturonate. D-Galacturonate is the main constituent of pectin. Pectin-rich biomass is abundantly available as sugar beet pulp or citrus processing waste and is currently mainly used as cattle feed. Other naturally occurring hexuronates are D-glucuronate, L-guluronate, D-mannuronate and L-iduronate. D-Glucuronate is a constituent of the plant cell wall polysaccharide glucuronoxylan and of the algal polysaccharide ulvan. Ulvan also contains L-iduronate. L-Guluronate and D-mannuronate are the monomers of alginate. These raw materials have the potential to be used as raw material in biotechnology-based production of fuels or chemicals. In this communication, we will review the microbial pathways related to these hexuronates and their potential use in biotechnology.

Indexed as

D-GalacturonateD-GlucuronatePectin

Identifiers

PMID30701402
PMCPMC6353982
OpenAlexW2936287677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.